May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Comparison of the Effects of Tafluprost, Latanoprost and Travoprost on the Optic Nerve Head Blood Flow in Rabbits
Author Affiliations & Notes
  • T. Akaishi
    Research and Development Center, Santen Pharmaceutical Co., Ltd., Ikoma-shi, Japan
  • H. Kurashima
    Research and Development Center, Santen Pharmaceutical Co., Ltd., Ikoma-shi, Japan
  • N. Odani
    Research and Development Center, Santen Pharmaceutical Co., Ltd., Ikoma-shi, Japan
  • N. Ishida
    Research and Development Center, Santen Pharmaceutical Co., Ltd., Ikoma-shi, Japan
  • A. Shimazaki
    Research and Development Center, Santen Pharmaceutical Co., Ltd., Ikoma-shi, Japan
  • Footnotes
    Commercial Relationships T. Akaishi, Santen Pharmaceutical Co., Ltd., E; H. Kurashima, Santen Pharmaceutical Co., Ltd., E; N. Odani, Santen Pharmaceutical Co., Ltd., E; N. Ishida, Santen Pharmaceutical Co., Ltd., E; A. Shimazaki, Santen Pharmaceutical Co., Ltd., E.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 2278. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Akaishi, H. Kurashima, N. Odani, N. Ishida, A. Shimazaki; Comparison of the Effects of Tafluprost, Latanoprost and Travoprost on the Optic Nerve Head Blood Flow in Rabbits. Invest. Ophthalmol. Vis. Sci. 2007;48(13):2278.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Tafluprost is a new-generation prostanoid FP-receptor agonist, which is a potent ocular hypotensive agent. The aim of this study was to evaluate and compare the effects of tafluprost, latanoprost and travoprost on optic nerve head (ONH) blood flow in rabbits.

Methods:: Male Dutch rabbits housed under a 12-hour light-dark cycle were used in this study. A quantitative index of blood flow, squared blur rate (SBR), was determined with the laser speckle method. Fifty µL of 0.0015% tafluprost, 0.005% latanoprost or 0.004% travoprost were topically administrated into the left eye once daily for 28 days. The blood flow was measured before treatment and 14 or 28 days after treatment with these prostanoid FP-receptor agonists. Measurement of the ONH blood flow was performed in the same area in each animal during the experiment.

Results:: After 28 days of administering tafluprost, latanoprost and travoprost, the trough SBR values became 111.9 ± 3.9%, 107.2 ± 4.3% and 106.7 ± 3.5% compared with the values before administration, respectively. Sixty minutes after final administration on day 28, the SBR values of tafluprost, latanoprost and travoprost became 116.1 ± 3.5%, 106.1 ± 3.0% and 104.2 ± 3.7% compared with the values before administration, respectively.

Conclusions:: These results indicate that topical administrations of prostanoid FP receptor agonists stably increase the ONH blood flow in rabbits. The magnitude of increase in ONH blood flow produced by tafluprost was greater than that of latanoprost or travoprost.

Keywords: blood supply • optic disc • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×